Washington HB 1665: Allowing pharmacists to treat certain conditions.
Status: By resolution, reintroduced and retained in present status. (as of 2024-01-08)
State: Washington · Session: 2023-2024 · Bill: HB 1665
Sponsors: Stonier, Pollet, Santos
Bill Text
AN ACT Relating to allowing pharmacists to treat certain 1 conditions; amending RCW 18.64.011; adding a new section to chapter 2 18.64 RCW; providing an effective date; and declaring an emergency.3 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:4 Sec. 1. RCW 18.64.011 and 2021 c 78 s 1 are each amended to read 5 as follows:6 The definitions in this section apply throughout this chapter 7 unless the context clearly requires otherwise.8 (1) "Administer" means the direct application of a drug or 9 device, whether by injection, inhalation, ingestion, or any other 10 means, to the body of a patient or research subject.11 (2) "Business licensing system" means the mechanism established 12 by chapter 19.02 RCW by which business licenses, endorsed for 13 individual state-issued licenses, are issued and renewed utilizing a 14 business license application and a business license expiration date 15 common to each renewable license endorsement.16 (3) "Chart order" means a lawful order for a drug or device 17 entered on the chart or medical record of an inpatient or resident of 18 an institutional facility by a practitioner or his or her designated 19 agent.20 H-0596.2 HOUSE BILL 1665 State of Washington68th Legislature2023 Regular Session By Representatives Stonier, Santos, and Pollet Read first time 01/30/23. Referred to Committee on Health Care & Wellness. p. 1HB 1665 (4) "Closed door long-term care pharmacy" means a pharmacy that 1 provides pharmaceutical care to a defined and exclusive group of 2 patients who have access to the services of the pharmacy because they 3 are treated by or have an affiliation with a long-term care facility 4 or hospice program, and that is not a retailer of goods to the 5 general public.6 (5) "Commission" means the pharmacy quality assurance commission.7 (6) "Compounding" means the act of combining two or more 8 ingredients in the preparation of a prescription. Reconstitution and 9 mixing of (a) sterile products according to federal food and drug 10 administration-approved labeling does not constitute compounding if 11 prepared pursuant to a prescription and administered immediately or 12 in accordance with package labeling, and (b) nonsterile products 13 according to federal food and drug administration-approved labeling 14 does not constitute compounding if prepared pursuant to a 15 prescription.16 (7) "Controlled substance" means a drug or substance, or an 17 immediate precursor of such drug or substance, so designated under or 18 pursuant to the provisions of chapter 69.50 RCW.19 (8) "Deliver" or "delivery" means the actual, constructive, or 20 attempted transfer from one person to another of a drug or device, 21 whether or not there is an agency relationship.22 (9) "Department" means the department of health.23 (10) "Device" means instruments, apparatus, and contrivances, 24 including their components, parts, and accessories, intended (a) for 25 use in the diagnosis, cure, mitigation, treatment, or prevention of 26 disease in human beings or other animals, or (b) to affect the 27 structure or any function of the body of human beings or other 28 animals.29 (11) "Dispense" means the interpretation of a prescription or 30 order for a drug, biological, or device and, pursuant to that 31 prescription or order, the proper selection, measuring, compounding, 32 labeling, or packaging necessary to prepare that prescription or 33 order for delivery.34 (12) "Distribute" means the delivery of a drug or device other 35 than by administering or dispensing.36 (13) "Drug" and "devices" do not include surgical or dental 37 instruments or laboratory materials, gas and oxygen, therapy 38 equipment, X-ray apparatus or therapeutic equipment, their component 39 parts or accessories, or equipment, instruments, apparatus, or 40 p. 2HB 1665 contrivances used to render such articles effective in medical, 1 surgical, or dental treatment, or for use or consumption in or for 2 mechanical, industrial, manufacturing, or scientific applications or 3 purposes. "Drug" also does not include any article or mixture covered 4 by the Washington pesticide control act (chapter 15.58 RCW), as 5 enacted or hereafter amended, nor medicated feed intended for and 6 used exclusively as a feed for animals other than human beings.7 (14) "Drugs" means:8 (a) Articles recognized in the official United States 9 pharmacopoeia or the official homeopathic pharmacopoeia of the United 10 States;11 (b) Substances intended for use in the diagnosis, cure, 12 mitigation, treatment, or prevention of disease in human beings or 13 other animals;14 (c) Substances (
View Washington HB 1665 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.